GAMBACORTI PASSERINI CARLO

Role
Full Professor  
Academic disciplines
Malattie del sangue (MED/15)
Email
[email protected]
Office phone
0264488362
0264488057
Room:
  • U08, Floor: 4, Room: 4-12
  • U08, Floor: 4, Room: 4041

Publications

  • Zappaterra, A., Civettini, I., Cafro, A., Pezzetti, L., Pierini, S., Anghilieri, M., et al. (2024). Anti-CD38 monoclonal antibody impairs CD34+ mobilization and affects clonogenic potential in multiple myeloma patients. BLOOD TRANSFUSION, 1-13 [10.2450/BloodTransfus.667]. Detail

  • Elli, E., Mauri, M., D’Aliberti, D., Crespiatico, I., Fontana, D., Redaelli, S., et al. (2024). Idiopathic erythrocytosis: a germline disease?. CLINICAL AND EXPERIMENTAL MEDICINE, 24(1) [10.1007/s10238-023-01283-y]. Detail

  • Crespiatico, I., Zaghi, M., Mastini, C., D'Aliberti, D., Mauri, M., Mercado, C., et al. (2024). First-hit SETBP1 mutations cause a myeloproliferative disorder with bone marrow fibrosis. BLOOD [10.1182/blood.2023021349]. Detail

  • Fontana, D., Zambrotta, G., Scannella, A., Piazza, R., Gambacorti-Passerini, C. (2024). Late relapse of chronic myeloid leukemia after allogeneic bone marrow transplantation points to KANSARL (KANSL1::ARL17A) alteration: a case report with insights on the molecular landscape. ANNALS OF HEMATOLOGY [10.1007/s00277-024-05649-4]. Detail

  • Zamprogna, G., Frustaci, A., Travi, G., Borella, C., Reda, G., Motta, M., et al. (2023). Tixagevimab/Cilgavimab Pre-exposure Prophylaxis in Patients with Lymphoproliferative Disorders on BTKi. HEMASPHERE, 7(5), 1-4 [10.1097/HS9.0000000000000880]. Detail

Full list

Research projects

Bioinformatic integration of clonal hierarchies, mutational and functional landscapes of tumors to build a theragnostic tool in cancer treatment
Year: 2021
Call: FAQC 2021 - terza finestra
Grantors: Università degli Studi di MILANO-BICOCCA
FANTOM - Future of ALCL: Novel Therapies, Origins, Bio-Markers and Mechanism of resistance
Year: 2021
Call: MSCA Doctoral Networks 2021
Grantors: EUROPEAN COMMISSION
Molecular pathogenesis of atypical CML: Converting NGS-obtained data into therapeutically relevant information - V annualità
Year: 2021
Call: 2017-005 - Call for Proposals 2017 Investigator Grant (IG)
Grantors: FONDAZIONE AIRC
Molecular pathogenesis of atypical CML: Converting NGS-obtained data into therapeutically relevant information - IV annualità
Year: 2020
Call: 2017-005 - Call for Proposals 2017 Investigator Grant (IG)
Grantors: FONDAZIONE AIRC
HARMONY PLUS-Clonal hierarchy in CML
Year: 2019
Call: Restricted Call to maximise impact of IMI2 JU objectives and scientific priorities
Grantors: EUROPEAN COMMISSION

Awards

Awards

  • ABILITAZIONE SCIENTIFICA NAZIONALE A PROFESSORE DI I FASCIA, SSD MED015, MIUR, 2013

Research and teaching assignments

  • Professore a contratto - Professor of Oncology and hematology, Canada research Chair, Dept of Oncology, Jewish General Hospital, Montreal, Canadà - McGill University, 2003 - 2008

Congresses/Conferences

  • Program chair - 5th ERIA meeting, "20 year of anniversary of the discovery of ALK", 2014